{ }
The global clinical biomarkers market, valued at $25.02 billion in 2023, is projected to reach $47.25 billion by 2031, growing at a CAGR of 8.54%. This growth is driven by rising cancer cases and advancements in diagnostic technologies, despite challenges like high costs and reimbursement issues. Key players include Roche, Abbott, and Johnson & Johnson, with significant developments in biomarker testing for various diseases.
Asian shares mostly rose, following a Wall Street rally, as U.S. inflation data suggested potential Federal Reserve support for the economy. The Hang Seng surged 1.4%, while the Nikkei 225 gained 1.2%. In the U.S., the S&P 500 climbed 0.8%, driven by tech stocks, despite a slight dip in the Dow.
Asian shares rose as Wall Street's rally continued, buoyed by an inflation update that suggests potential Federal Reserve support for the economy. The Hang Seng surged 1.7%, while Tokyo's Nikkei 225 gained 1.3%, driven by technology stocks. In the U.S., the S&P 500 climbed 0.8%, with Tesla jumping 5.9% and Stitch Fix soaring 44.3% after better-than-expected earnings.
Asian shares rose Thursday, buoyed by a Wall Street rally and positive inflation updates that may lead to further Federal Reserve support for the economy. The Hang Seng surged 1.7%, while the Nikkei 225 gained 1.3%, driven by technology stocks. In the U.S., the S&P 500 climbed 0.8%, marking its first two-day gain in nearly a month, as inflation ticked up slightly to 2.7% in November.
Asian shares rose Thursday, buoyed by a Wall Street rally and positive inflation updates that may lead to Federal Reserve support for the economy. The Hang Seng surged 1.7%, while Tokyo's Nikkei 225 gained 1.3%, driven by technology stocks. In the U.S., the S&P 500 climbed 0.8%, marking its first two-day gain in nearly a month, as expectations for interest rate cuts fueled market optimism.
Stock futures are mostly flat as investors await key inflation data, with Dow futures up 18 points and S&P 500 and Nasdaq 100 futures each rising 0.1%. Economists expect November's consumer price index to increase by 0.3% from October and 2.7% year-over-year, while core CPI is projected to rise 0.3% monthly and 3.3% annually. Market participants are in a "waiting mode" ahead of the data, with concerns about inflation impacting trading momentum.
General Electric Co, founded in 1892, has undergone a significant transformation, culminating in a breakup into three distinct companies. The third entity, GE Vernova, led by CEO Scott Strazik, focuses on clean energy solutions, including wind turbines, nuclear power, carbon capture, and grid technologies.
GE Vernova aims to lead the deployment of small modular reactors (SMRs) like the BWRX-300 across developed nations, targeting over $2 billion in annual revenue by the mid-2030s. The reactor's simpler design allows for reduced construction costs and flexibility in location, with plans for commercial deployment in North America by 2029. Interest from tech companies seeking reliable energy for data centers further drives demand for nuclear power, as utilities explore smaller, less risky projects.
Data Bridge Market Research has successfully catered to over 40% of Fortune 500 companies globally, boasting a clientele of more than 5,000 and a remarkable 99.9% client satisfaction rate. The firm specializes in market research and consulting, focusing on uncovering opportunities and providing solutions to complex business challenges. In the radiology sector, key players like Siemens Healthineers, GE Healthcare, and Philips Healthcare are driving innovation and enhancing diagnostic capabilities through advanced technologies. The report highlights market trends, growth potential, and competitive analysis across various regions, emphasizing the importance of informed decision-making for B2B companies.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.